411 related articles for article (PubMed ID: 4067309)
1. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
Boyce NW; Holdsworth SR
J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of chemo-attractant and terminal components of complement to anti-glomerular basement membrane (GBM) glomerulonephritis.
Tipping PG; Boyce NW; Holdsworth SR
Clin Exp Immunol; 1989 Dec; 78(3):444-8. PubMed ID: 2612054
[TBL] [Abstract][Full Text] [Related]
3. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the glomerular protein leak after polyclonal activation in the HgCl2-induced model of anti-GBM disease in the brown Norway rat.
Savige JA; Lockwood CM
Clin Exp Immunol; 1987 Dec; 70(3):619-29. PubMed ID: 3436100
[TBL] [Abstract][Full Text] [Related]
5. Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat.
Feintzeig ID; Abrahamson DR; Cybulsky AV; Dittmer JE; Salant DJ
Lab Invest; 1986 May; 54(5):531-42. PubMed ID: 3517487
[TBL] [Abstract][Full Text] [Related]
6. The acute effects of antiglomerular basement membrane antibody upon glomerular filtration in the rat. The influence of dose and complement depletion.
Blantz RC; Tucker BJ; Wilson CB
J Clin Invest; 1978 Apr; 61(4):910-21. PubMed ID: 659582
[TBL] [Abstract][Full Text] [Related]
7. Experimental glomerulonephritis in the guinea pig. II. Ultrastructural lesions of the basement membrane associated with proteinuria.
Couser WG; Spargo BH; Stilmant MM; Lewis EJ
Lab Invest; 1975 Jan; 32(1):46-55. PubMed ID: 1089838
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
Holdsworth SR; Tipping PG
J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
[TBL] [Abstract][Full Text] [Related]
9. The role of C3 in the autologous phase of nephrotoxic nephritis.
Thomson NM; Naish PF; Simpson IJ; Peters DK
Clin Exp Immunol; 1976 Jun; 24(3):464-73. PubMed ID: 939050
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits.
Tipping PG; Leong TW; Holdsworth SR
Lab Invest; 1991 Sep; 65(3):272-9. PubMed ID: 1890807
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis.
Sindrey M; Marshall TL; Naish P
Clin Exp Immunol; 1979 Apr; 36(1):90-6. PubMed ID: 157239
[TBL] [Abstract][Full Text] [Related]
12. Evidence for direct renal injury as a consequence of glomerular complement activation.
Boyce NW; Holdsworth SR
J Immunol; 1986 Apr; 136(7):2421-5. PubMed ID: 3950418
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophiles.
Lianos EA
J Clin Invest; 1988 Aug; 82(2):427-35. PubMed ID: 2841352
[TBL] [Abstract][Full Text] [Related]
14. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1.
Tomosugi NI; Cashman SJ; Hay H; Pusey CD; Evans DJ; Shaw A; Rees AJ
J Immunol; 1989 May; 142(9):3083-90. PubMed ID: 2785133
[TBL] [Abstract][Full Text] [Related]
15. Guinea-pig nephrotoxic nephritis. I. The role of complement and polymorphonuclear leucocytes and the effect of antibody subclass and fragments in the heterologous phase.
Simpson IJ; Amos N; Evans DJ; Thomson NM; Peters DK
Clin Exp Immunol; 1975 Mar; 19(3):499-511. PubMed ID: 1106914
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A and anti-glomerular basement membrane antibody glomerulonephritis in rats.
Wood A; Adu D; Birtwistle RJ; Brewer DB; Michael J
Br J Exp Pathol; 1988 Apr; 69(2):189-95. PubMed ID: 3259890
[TBL] [Abstract][Full Text] [Related]
17. [Role of complement in experimental glomerulonephritis].
Parra Borges G; Mosquera J; RodrÃguez-Iturbe B
Invest Clin; 1991; 32(2):91-105. PubMed ID: 1807401
[TBL] [Abstract][Full Text] [Related]
18. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat.
Bagchus WM; Hoedemaeker PJ; Rozing J; Bakker WW
Lab Invest; 1986 Dec; 55(6):680-7. PubMed ID: 3537521
[TBL] [Abstract][Full Text] [Related]
19. Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.
Thaiss F; Batsford S; Mihatsch MJ; Heitz PU; Bitter-Suermann D; Vogt A
Lab Invest; 1986 Jun; 54(6):624-35. PubMed ID: 2940417
[TBL] [Abstract][Full Text] [Related]
20. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
